Larvol Delta - Blade-Therapeutics-Announces-Positive-Data-from-Preclinical-DrugDrug-Interaction-Study-of-Cudetaxestat-a-NonCompetitive-Autotaxin-Inhibitor-in-Clinical-Development-for-Idiopathic-Pulmonary-Fibrosis-IPF

cudetaxestat (BLD 0409) - Blade Therap

https://www.businesswire.com/news/home/20210920005244/en/Blade-Therapeutics-Announces-Positive-Data-from-Preclinical-Drug-Drug-Interaction-Study-of-Cudetaxestat-a-Non-Competitive-Autotaxin-Inhibitor-in-Clinical-Development-for-Idiopathic-Pulmonary-Fibrosis-IPF

Sep 20, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next